![David Lowenschuss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Lowenschuss was the founder of Gemphire Therapeutics, Inc. which he founded in 2014 and served as Secretary & Chief Legal Officer.
Currently, he is the Chief Business Officer at Mekanistic Therapeutics LLC.
Mr. Lowenschuss has a graduate degree from George Washington University and both undergraduate and graduate degrees from the University of Michigan.
| Sociétés | Poste | Début |
|---|---|---|
Mekanistic Therapeutics LLC
 Mekanistic Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biotechnology company which develops anti-cancer drugs | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| METAVIA INC. | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
Mekanistic Therapeutics LLC
Mekanistic Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biotechnology company which develops anti-cancer drugs | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
